-
From the Editor-in-Chief
Cancer in Minority PopulationsPaying attention to the social determinants of health will promote greater equity in cancer outcomes for all.
by William G. Nelson, MD, PhD
-
Targeted Therapy for Early-Stage Lung Cancer?
A trial of the targeted therapy Tagrisso (osimertinib) for early-stage lung cancer finds that patients who take it go longer without having a cancer recurrence. Whether that should change clinical practice is under discussion.
by Ashley P. Taylor
-
Cervical Cancer Screening Guideline Updated
A new version of the American Cancer Society's cervical cancer screening guideline says screening can start at a later age and highlights human papillomavirus testing as the preferred method.
by Anna Azvolinsky
-
Support Grows for Making Transfusions a Part of Hospice
Blood cancer patients have low rates of enrollment in hospice. One barrier to enrollment is that many hospices do not provide blood transfusions.
by Jon Kelvey
-
Anal Cancer Diagnoses and Deaths Are Rising in the U.S.
Study underscores importance of early detection and prevention.
by Jane Langille
-
In It for the Long Haul
Doctors and researchers met online to discuss how the coronavirus pandemic changed cancer care in its early months, as well as how they can improve care and advocate for patients going forward.
by Kate Yandell
-
The Pandemic’s Impact on Cancer Screening and Detection
Delays in cancer screening and diagnosis due to the COVID-19 pandemic put people at risk.
by Kevin McLaughlin
-
From the Editor-in-Chief
Measuring a Cancer Drug’s EffectivenessSurrogate endpoints can speed up drug approvals, but are they valid measures of effectiveness?
by William G. Nelson, MD, PhD
-
Forward Look
Cancer Treatments and Antioxidant Supplements Can Be a Bad MixChristine Ambrosone on what her research shows.
by Sue Rochman
-
Forward Look
Here Come the BiosimilarsAs patents expire on biologic drugs, cancer patients get new options.
by Stephen Ornes
Cancer Talk
Cancer Today Editors’ Picks: 2024
Our favorite Cancer Today stories from 2024, as picked by the editors.
Rethinking the Role of RadiationChest radiation may not be necessary for people with intermediate-risk breast cancer.
by Thomas Celona
De-escalating Treatment for DCISResearch finds certain people with low-risk DCIS may be able to forgo surgery or radiation.
by Thomas Celona
Study Highlights Challenges in Pancreatic Cancer StagingMost pancreatic ductal adenocarcinoma cases initially considered to be stage I are changed to a higher stage after surgery.
by Taneia Surles